MedTrace Logo

Cardio-Oncology Registry

NCT04407780 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2020-05-29

No results posted yet for this study

Summary

Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias.

CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt.

The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.

Conditions

Interventions

OTHER

No interventions are planned

Non applicable

Sponsors & Collaborators

  • European Georges Pompidou Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2022-06-01
Completion
2027-06-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04407780 on ClinicalTrials.gov